Organ Preservation Market Revenue is expected to grow US$ 455 Mn by 2032 | Says FMI Analyst
The Organ Preservation Market Revenue is expected to grow US$ 455 Million by 2032, up from 230 million in 2021, at a 6.4% CAGR during the forecast period.
Organ Preservation Market Overview:
Organ preservation is the
practise of preserving healthy organs removed from donors’ bodies. Organs are
extracted from the donor’s body, transported, and then transplanted into the
recipient’s body without causing significant damage. According to the findings
of this study, the rising prevalence of chronic illnesses has a direct impact
on the adoption of organ preservation.
Organ Preservation
Organ
preservation for transplantation has a strong influence on donor organ
quality, which has a direct impact on a patient’s morbidity and survival rates
following transplantation. One of the major factors driving the growth of the
organ preservation solutions market is the increasing prevalence of chronic
illnesses, as well as the world’s growing elderly population.
Because of the increasing
number of organ failures caused by diabetes, cardiovascular diseases (CVDs),
obesity, and other serious medical problems, static cold storage organ
preservation treatments are becoming more common. Innovative and sophisticated
organ preservation strategies, such as NMP, act as a growth-inducing agent.
Key Takeaways:
- A preservation injury occurs when the
liver no longer functions. A liver transplant, also known as a hepatic
transplant, has the potential to save someone’s life. A liver transplant
may also be recommended by a doctor to a patient who has reached the end
stage of liver disease.
- Individuals who received a liver
transplant had an 89% chance of survival after one year, according to an
article published in the American Journal of Transplantation. The growing
need for organ transplantation is propelling the global organ preservation
market across the board.
- According to the American Transplant
Foundation, approximately 114,000 people in the United States are
currently on the waiting list for a life-saving organ transplant. Every
day, on average, 20 people die due to a lack of available organs for
transplantation.
Competition
Analysis:
The global organ
preservation market is dominated by companies such as Paragonix Technologies
(US), XVIVO Perfusion AB (Sweden), Dr Franz Köhler Chemie GmbH (Germany),
Essential Pharmaceuticals, LLC (US), TransMedics (US), OrganOx Limited (UK),
21st Century Medicine (US), Bridge to Life Limited (US), Waters Medical Systems
(US), Preservation Solutions (US), Carnamedica (Poland), Transplant Biomedicals
(Spain), Institut (Netherlands).
To
learn more about this report @ https://www.futuremarketinsights.com/reports/organ-preservation-market
Comments
Post a Comment